CAS: 1322625-54-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Lopinavir-d8 REF: 4Z-L-302CAS: | - - - | To inquire | Tue 07 Jan 25 |
 | Lopinavir-d8 REF: TR-L469482CAS: 1322625-54-6 | - - - | 493.00 €~3,469.00 € | Thu 16 Jan 25 |
 | Lopinavir-d8 REF: 3D-XCC62554CAS: 1322625-54-6 | Min. 95% | 863.00 €~4,869.00 € | Tue 18 Feb 25 |
Ref: 4Z-L-302
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Lopinavir-d8
Controlled ProductCAS:1322625-54-6
Applications A labelled selective HIV protease inhibitor. An analogue of Ritonavir. Antiviral. It is a …
Formula:
C37D8H40N4O5
Color and Shape:
Light Yellow
Molecular weight:
636.85
Ref: TR-L469482
| 1mg | 493.00 € | ||
| 10mg | 3,469.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Lopinavir-d8
CAS:1322625-54-6
Lopinavir is an antiviral drug used for the treatment of HIV infection. Lopinavir-d8 is a …
Formula:
C37H48N4O5
Purity:
Min. 95%
Molecular weight:
636.8 g/mol
Ref: 3D-XCC62554
| 1mg | 863.00 € | ||
| 2mg | 1,392.00 € | ||
| 5mg | 2,898.00 € | ||
| 10mg | 4,869.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
